Prof Sharon Peacock FMedSci CBE
Executive Director and Chair, COVID-19 Genomics UK (COG-UK) Consortium
Professor of Public Health & Microbiology, University of Cambridge
Sharon Peacock has worked in academic clinical microbiology across the United Kingdom and South East Asia for the last 25 years. She is currently Professor of Public Health and Microbiology in the Department of Medicine, University of Cambridge; Executive Director of the COVID-19 Genomics UK (COG-UK) consortium; and a Non-Executive Director on the board of Cambridge University Hospitals NHS Foundation Trust. Sharon has built her scientific reputation around pathogen genomics, antimicrobial resistance, and a range of tropical diseases. She has also sought to influence policy in relation to the use of pathogen genomics in the UK over the last decade. She was a member of the UK Department of Health Genomics Working Group on Scientific Priorities for the 100,000-genome project in 2013, when she chaired the subgroup on infectious diseases. One of several recommendations was the introduction of routine public health sequencing of Mycobacterium tuberculosis. She also led the chapter content on pathogen genomics in the Annual Report of the Chief Medical Officer 2016: Generation Genome. Professor Peacock has published more than 500 peer reviewed papers and manages >£38M of funding. She is a Fellow of the Academy of Medical Sciences, a Fellow of the American Academy of Microbiology, and an elected Member of EMBO. In 2015, Peacock received a CBE for services to medical microbiology, and in 2018 she won the Unilever Colworth Prize for her outstanding contribution to translational microbiology.